Metlife (MET) Liabilities and Shareholders Equity (2009 - 2026)

Metlife's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $743.2 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 151575.71% year-over-year to $743.2 billion; the TTM figure through Mar 2026 stood at $2910.6 billion (up 41.38% YoY), while the FY2025 annual figure was $745.2 billion, up 9.99% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $743.2 billion, roughly flat from $745.2 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $745.2 billion in Q4 2025, with the low at $490.0 million in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $677.5 billion (2024), against an average of $649.3 billion.
• The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity slumped 99.93% in 2025, then surged 151575.71% in 2026.
• Metlife's Liabilities and Shareholders Equity stood at $663.1 billion in 2022, then grew by 3.7% to $687.6 billion in 2023, then retreated by 1.47% to $677.5 billion in 2024, then rose by 9.99% to $745.2 billion in 2025, then decreased by 0.26% to $743.2 billion in 2026.
• Business Quant data shows MET's Liabilities and Shareholders Equity at $743.2 billion in Q1 2026, $745.2 billion in Q4 2025, and $719.7 billion in Q3 2025.